Mesco Pharmaceuticals Ltd

MESCOPHARMACEUTICALS10 Jan 2022

Pharmaceuticals

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Mesco Pharmaceuticals Ltd

Mesco Pharmaceuticals Ltd

Pharmaceuticals

MESCOPHARMACEUTICALS10 Jan 2022

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
09-Nov-2023	BC	Trading Members of the Exchange are hereby informed that the undermentioned 6 companies that have remained suspended for more than 6 months would be delisted from the platform of the Exchange, with e	12-Nov-2023
12-May-2022	BC	This is in continuation to Exchange Notice No. 20211012-25 dated October 12, 2021 wherein the Trading Members were advised that w.r.t to the following companies, 15 days after suspension had been eff	24-May-2022
09-Feb-2022	BC	MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve 1. To consider and approve the stand	14-Feb-2022
20-Oct-2021	BC	Pursuant to the provisions of Circular No. SEBI/HO/CFD/CMD/CIR/P/2020/12 dated January 22, 2020 issued by Securities and Exchange Board of India (SEBI) with respect to Standard Operating Procedure (S	22-Nov-2021
12-Oct-2021	BC	Pursuant to the provisions of Circular No. SEBI/HO/CFD/CMD/CIR/P/2020/12 dated January 22, 2020 issued by Securities and Exchange Board of India (SEBI) with respect to Standard Operating Procedure (S	12-Nov-2021

No Rights has been declared by MESCOPHARMACEUTICALS

Book Closure

Record Date	Split Date	Purpose
12-Nov-2023	-	Trading Members of the Exchange are hereby informed that the undermentioned 6 companies that have remained suspended for more than 6 months would be delisted from the platform of the Exchange, with e
24-May-2022	-	This is in continuation to Exchange Notice No. 20211012-25 dated October 12, 2021 wherein the Trading Members were advised that w.r.t to the following companies, 15 days after suspension had been eff
14-Feb-2022	-	MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve 1. To consider and approve the stand
22-Nov-2021	-	Pursuant to the provisions of Circular No. SEBI/HO/CFD/CMD/CIR/P/2020/12 dated January 22, 2020 issued by Securities and Exchange Board of India (SEBI) with respect to Standard Operating Procedure (S
12-Nov-2021	-	Pursuant to the provisions of Circular No. SEBI/HO/CFD/CMD/CIR/P/2020/12 dated January 22, 2020 issued by Securities and Exchange Board of India (SEBI) with respect to Standard Operating Procedure (S

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Mesco Pharmaceuticals Ltd ₹4.54(0.00/0.00%)	4.54	+0.00	9.23	-39.39	0.00	-0.88
Ambalal Sarabhai Enterprises Ltd ₹58.37(+0.38/0.66%)	58.37	+0.38	447.31	43.06	50.76	9.93
Astrazeneca Pharma India Ltd ₹6,632.55(+2.00/0.03%)	6,632.55	+2.00	16,581.38	37.91	128.81	24.41
Abbott India Ltd ₹29,053.50(+29.75/0.10%)	29,053.50	+29.75	61,738.69	25.91	48.06	17.53
Amrutanjan Health Care Ltd ₹722.80(-15.20/-2.06%)	722.80	-15.20	2,089.66	21.23	43.97	7.02
Bliss GVS Pharma Ltd ₹157.90(-2.90/-1.80%)	157.90	-2.90	1,663.19	18.28	20.59	1.62

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Cash and Cash Equivalents at Beginning of the year	0.04	0.04	0.04	0.04	0.04
Net Cash from Operating Activities	0.00	-0.08	-0.39	-0.09	-0.26
Net Cash Used In Investing Activities	0.00	0.00	0.00	0.00	0.00
Net Cash Used In Financing Activities	-0.03	0.08	0.39	0.09	0.26
Net Inc./Dec In Cash And Cash Equivalents	-0.04	0.00	0.00	0.00	0.00
Cash And Cash Equivalents At End Of The Year	0.00	0.04	0.04	0.04	0.04

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

39.30%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

60.70%

**Promoter pledged shareholding 39.30%

About Mesco Pharmaceuticals Ltd

Mesco Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 9.23 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. 0 crores for the quarter ended December 2018. The company management includes , Dushyant Kumar Singh,N S Parameshwaran,Hawa Singh Chahar,Dhruv Singh (Mesco Pharmaceuticals Ltd) among others.

Chairman

Registered office

Upper Kesalton,Tallital,Nainital,Uttar Pradesh,263001

FAX :

Background

Incorporation Year1986

Face Value₹10

Market Lot1